Skip to main content
Top
Published in: AIDS and Behavior 1/2009

01-02-2009 | Original Paper

Adherence to Anti Retroviral Therapy (ART) During Muslim Ramadan Fasting

Authors: A. G. Habib, J. C. Shepherd, M. K. L. Eng, M. Babashani, J. Jumare, U. Yakubu, U. I. Gebi, M. Saad, H. Ibrahim, W. A. Blattner

Published in: AIDS and Behavior | Issue 1/2009

Login to get access

Abstract

Annual fasting during the month of Ramadan is observed in Muslim countries, some of which have widespread HIV infection. We studied treatment adherence and customary practices among 142 fasting ‘FT’ and 101 non-fasting ‘NFT’ patients on anti-retroviral therapy (ART) in Nigeria. Adherence on ART among FT and NFT patients was similar during Ramadan, 96% and 98%, and ever since commencement of ART, 80% and 88%, respectively. FT patients altered their typical daily behaviors by advancing morning and delaying evening doses thereby prolonging dosing intervals, eating heavier meals pre-dawn and on breakfast at sunset (78%), and changing or reducing their sleeping and waking times (40%). This preliminary study suggests that adherence and drug taking frequency appear uncompromised in FT HIV infected patients on ARVs.
Literature
go back to reference Burger, D. M., Hoetelmans, R. M., Hugen, P. W., Mulder, J. W., Meenhorst, P. L., Koopmans, P. P., et al. (1998). Low plasma concentrations of indinavir are related to virological treatment failure in HIV–1 infected patients on indinavir-containing triple therapy. Antiviral Therapy, 3, 215–220. Medline.PubMed Burger, D. M., Hoetelmans, R. M., Hugen, P. W., Mulder, J. W., Meenhorst, P. L., Koopmans, P. P., et al. (1998). Low plasma concentrations of indinavir are related to virological treatment failure in HIV–1 infected patients on indinavir-containing triple therapy. Antiviral Therapy, 3, 215–220. Medline.PubMed
go back to reference Crane, J. R., Perlman, S., Meredith, K. L., Jeffe, D. B., Fraser, V. J., Lucas, A. M., et al. (2000). Women with HIV: Conflicts and synergy of prayer within the realm of medical care. AIDS Education and Prevention, 12, 532–543. Medline.PubMed Crane, J. R., Perlman, S., Meredith, K. L., Jeffe, D. B., Fraser, V. J., Lucas, A. M., et al. (2000). Women with HIV: Conflicts and synergy of prayer within the realm of medical care. AIDS Education and Prevention, 12, 532–543. Medline.PubMed
go back to reference Hsu, A., Granneman, R., Witt, G., Locke, C., Denissen, J., Molla, A., et al. (1997). Multiple-dose pharmacokinetics of ritonovir in human immunodefciency virus infected subjects. Antimicrobial Agents and Chemotherapy, 41, 898–905. Medline.PubMed Hsu, A., Granneman, R., Witt, G., Locke, C., Denissen, J., Molla, A., et al. (1997). Multiple-dose pharmacokinetics of ritonovir in human immunodefciency virus infected subjects. Antimicrobial Agents and Chemotherapy, 41, 898–905. Medline.PubMed
go back to reference Piot, P., & Coll Seck, A. M. (2001). Interntaional response to HIV/AIDS epidemic: Planning for success. Bulletin of the World Health Organization, 79, 1106–1112. Medline.PubMed Piot, P., & Coll Seck, A. M. (2001). Interntaional response to HIV/AIDS epidemic: Planning for success. Bulletin of the World Health Organization, 79, 1106–1112. Medline.PubMed
go back to reference Van Heeswijk, R. P. G., Bourbeau, M., Seguin, I., Giguere, P., Garber, G. E., & Cameron, D. W. (2005). Absence of circadian variation in the pharmacokinetics of lopinavir/ritonovir given as a once daily dosing regimen in HIV-1 infected patients. British Journal of Clinical Pharmacology, 59, 398–404. doi:10.1111/j.1365-2125.2005.02337.x.PubMedCrossRef Van Heeswijk, R. P. G., Bourbeau, M., Seguin, I., Giguere, P., Garber, G. E., & Cameron, D. W. (2005). Absence of circadian variation in the pharmacokinetics of lopinavir/ritonovir given as a once daily dosing regimen in HIV-1 infected patients. British Journal of Clinical Pharmacology, 59, 398–404. doi:10.​1111/​j.​1365-2125.​2005.​02337.​x.PubMedCrossRef
Metadata
Title
Adherence to Anti Retroviral Therapy (ART) During Muslim Ramadan Fasting
Authors
A. G. Habib
J. C. Shepherd
M. K. L. Eng
M. Babashani
J. Jumare
U. Yakubu
U. I. Gebi
M. Saad
H. Ibrahim
W. A. Blattner
Publication date
01-02-2009
Publisher
Springer US
Published in
AIDS and Behavior / Issue 1/2009
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-008-9412-2

Other articles of this Issue 1/2009

AIDS and Behavior 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.